Back to Stakeholders
HospitalsIndependent Academic Research Groups

Medical University of Gdansk

Poland
12 Trials

The Medical University of Gdańsk is Poland's leading academic medical institution, with its Department of Psychiatry running one of the country's most active research programs on ketamine and esketamine for treatment-resistant depression and bipolar disorder.

Quick Facts

Type
Other
HQ
Poland
Website
Visit

Sponsored Trials

11
Not yet recruitingIII

Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain

Start Date
Compounds
Ketamine, Placebo
CompletedI

Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder

Start Date
Compounds
Ketamine
CompletedNA

Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression

Start Date
Enrolling by invitationNA

Observation of Ketamine Treatment Safety and Tolerability in Adult Psychiatry Clinic Medical University of Gdańsk Inpatients

Start Date
Compounds
Ketamine
RecruitingNA

Ketamine and Stress in OCD

Start Date
Compounds
Ketamine, Placebo
RecruitingI

The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects

Start Date
Compounds
Ketamine, Placebo
TerminatedII

KAP for Depression in Abstinent Opioid Users (KReDO)

Start Date
Compounds
Ketamine
CompletedII

Ketamine for the Treatment of Opioid Use Disorder and Depression

Start Date
Compounds
Ketamine, Placebo
RecruitingI

Imaging Neural Correlates of Ketamine Using PET/MR

Start Date
Compounds
Esketamine, Placebo, Ketamine
CompletedNA

A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders

Start Date
Compounds
Ketamine
Unknown statusII

Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter

Start Date
Compounds
Esketamine, Placebo, Ketamine

Collaborated Trials

1
RecruitingIII

Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

Start Date
Compounds
Placebo, Ketamine